The authors observed that FMT from responding patients but not from non-responding patients into GF mice caused tumor growth delay, accumulation of CXCR3+CD4+ T cells in the tumor microenvironment, and up-regulation of PD-L1 in splenic T cells after PD-1 blockade. The gene discussed is PDCD1; the disease is neoplasm.